Ads
related to: vaginal cancer
Search results
Results From The WOW.Com Content Network
Vaginal cancer is an extraordinarily rare form of cancer that develops in the tissue of the vagina. [1] Primary vaginal cancer originates from the vaginal tissue – most frequently squamous cell carcinoma , but primary vaginal adenocarcinoma, sarcoma, and melanoma have also been reported [ 2 ] – while secondary vaginal cancer involves the ...
Squamous cell carcinoma of the vagina is a potentially invasive type of cancer that forms in the tissues of the vagina.Though uncommonly diagnosed, squamous cell cancer of the vagina (SCCV) is the most common type of vaginal cancer, accounting for 80-90% of cases as well as 2% of all gynecological cancers.
[8] [7] Cancer that has spread from the colon, bladder, and stomach is far more common than cancer that originates in the vagina itself. [9] Some benign tumors may later progress to become malignant tumors, such as vaginal cancers. [10] [11] Some neoplastic growths of the vagina are sufficiently rare as to be only described in case studies. [3]
Gynecologic cancer is a type of cancer that affects the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. Gynecological cancers comprise 10-15% of women's cancers, mainly affecting women past reproductive age but posing threats to fertility for younger patients. [ 1 ]
Vulvar cancer can produce lumps that are red, pink or white, and may feel rough or thick to the touch, as a symptom, and vaginal cancer, while rare, can also cause a lump.
Squamous cell carcinoma of the vagina spreads slowly and usually stays near the vagina, but may spread to the lungs and liver. This is the most common type of vaginal cancer . [ 12 ]
NHS England has promised to eliminate cervical cancer by 2040. Women aged 25-49 are encouraged to have a screening every three years, while women aged 50-64 should have one every five years.
Clear-cell adenocarcinoma of the vagina is a rare cancer, occurring in up to 10% of primary vaginal malignancies. It is all but confirmed if maternal use of DES is established. It is all but confirmed if maternal use of DES is established.